Skip to content

Comparison of utility of biopsy needle in EBUS-TBNA

Comparison of utility of biopsy needle in EBUS-TBNA - Comparison of utility of biopsy needle in EBUS-TBNA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029004
Enrollment
300
Registered
2017-09-05
Start date
2017-09-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, mediastinal/hilar lymph node swelling

Interventions

None listed

Sponsors

Chiba University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who received EBUS-TBNA.

Exclusion criteria

Exclusion criteria: Patients judged inappropriate by the attending.

Design outcomes

Primary

MeasureTime frame
Concordance of pathological findings

Secondary

MeasureTime frame
Rate of obtaining histological core, pathological area, quality of cytological samples (lymphocyte/bleeding score), rapid on site evaluation, diagnostic rate in each station

Countries

Japan

Contacts

Public ContactYuichi Sakairi

Chiba University Graduate School of Medicine General Thoracic Surgery

y_sakairi1@chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026